At the news
? BEARISHIMPACT 6/10 144 filed Aug 13, 2026 at 17:36 ET
Atlas Venture Fund XI, L.P., a major venture capital insider, filed a Form 144 on August 13, 2026, indicating intent to sell 268,354 shares of Dyne Therapeutics (DYN) with an approximate market value of $7.0 million. Separately, Director John Cox also filed a Form 144 on the same day, signaling a proposed sale. The Atlas Venture sale represents a significant insider liquidation by a founding investor, which is a bearish signal for the stock, especially given the company's pre-revenue status and reliance on pipeline catalysts. The batch of filings on the same day amplifies the negative sentiment, suggesting coordinated insider selling.
- Atlas Venture Fund XI, L.P. filed Form 144 to sell 268,354 shares of DYN, valued at approximately $7.0 million based on the filing date.
- Director John Cox also filed a Form 144 on the same day, indicating a proposed sale of an undisclosed number of shares.
- The Atlas Venture sale represents a significant portion of their holdings, as they are a founding venture capital investor.
- The filing date is August 13, 2026, with the proposed sale to occur on or after that date.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access